Understanding the new therapeutic options for mesothelioma
Lancet Oncol
.
2021 Oct;22(10):1353-1355.
doi: 10.1016/S1470-2045(21)00520-9.
Epub 2021 Sep 6.
Author
Hedy Lee Kindler
1
Affiliation
1
Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, USA. Electronic address: hkindler@medicine.bsd.uchicago.edu.
PMID:
34499875
DOI:
10.1016/S1470-2045(21)00520-9
No abstract available
MeSH terms
Humans
Mesothelioma*
Mesothelioma, Malignant*
Pleural Neoplasms*
Associated data
ClinicalTrials.gov/NCT02899195
ClinicalTrials.gov/NCT04334759